The Molecular Cytogenetics Core provides MSKCC investigators with effective chromosome-based analysis for both human and research animal cells and provides valuable support to investigators focused on understanding chromosomal instability in cancer, documentation of cell line identity and chromosomal integrity following genetic manipulations. The Molecular Cytogenetics Core processes samples from primary cells, cell lines, or archival tissue. The Core performs chromosome analysis on research samples, using conventional cytogenetics (chromosome banding and karyotyping) and molecular cytogenetics procedures based on fluorescence in situ hybridization (FISH), including Spectral Karyotyping. Staff assist investigators in designing the most appropriate and efficient analyses for their needs and produce customized probes for specific projects. The Core has assembled a broad range of molecular cytogenetics resources, including locus-specific plasmid and BAC done stocks, and individual whole chromosome painting probes. For example, the Massague lab examined the molecular basis of the link between metastasis and chemoresistance. Cancer cells that overexpress CXCL1/2 were examined. The Core provided preparation of specific probes and performed FISH to confirm sex-mismatched mouse bone marrow engraftment (XY FISH on blood smears), and performed CXCL1/2 DNA copy analysis on tissue sections of human breast tumor and metastases (frozen, paraffin, and tissue microarray) to demonstrate copy number increase and amplification. The services and collaborative work provided by the Molecular Cytogenetics Core have supported the research of 29 investigators in the past year. During the past grant period, the work of the Core has contributed to 101 publications of researchers from 6 research programs.

Public Health Relevance

Chromosome analysis is a fundamental component of cell-based research. Tumor cells frequently have highly rearranged karyotypes and even normal cells may acquire chromosomal abnormalities after extended periods in cell culture. MSKCC investigators regularly need to examine the chromosomal status of cells in a variety of ways, from isolated DNA to whole chromosomes in live cells. The Molecular Cytogenics core provides the services and expertise to meet these needs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-48
Application #
8933514
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
2014-01-01
Project End
2018-12-31
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
48
Fiscal Year
2014
Total Cost
$215,572
Indirect Cost
$94,260
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Meyer, Jan-Philip; Tully, Kathryn M; Jackson, James et al. (2018) Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers. Bioconjug Chem 29:538-545
McFarland, Daniel C; Shaffer, Kelly; Breitbart, William et al. (2018) C-reactive protein and its association with depression in patients receiving treatment for metastatic lung cancer. Cancer :
Lacouture, Mario E; Anadkat, Milan; Jatoi, Aminah et al. (2018) Dermatologic Toxicity Occurring During Anti-EGFR Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review. Clin Colorectal Cancer 17:85-96
Blumenthal, Gideon M; Bunn Jr, Paul A; Chaft, Jamie E et al. (2018) Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer. J Thorac Oncol 13:1818-1831
Shaffer, Kelly M; Nelson, Christian J; DuHamel, Katherine N (2018) Barriers to participation in a sexual health intervention for men following treatment for rectal and anal cancer. Psychooncology 27:1082-1085
Park, Kay J; Patel, Prusha; Linkov, Irina et al. (2018) Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy. Histopathology 72:766-776
Pianko, Matthew J; Goldberg, Aaron D; Lesokhin, Alexander M (2018) Clinical Development of PD-1 Blockade in Hematologic Malignancies. Cancer J 24:31-35
Navi, Babak B; Marshall, Randolph S; Bobrow, Dylan et al. (2018) Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial. JAMA Neurol 75:379-381
Shah, Sona; Boucai, Laura (2018) Effect of Age on Response to Therapy and Mortality in Patients With Thyroid Cancer at High Risk of Recurrence. J Clin Endocrinol Metab 103:689-697
Goldman, Debra A; Hovinga, Koos; Reiner, Anne S et al. (2018) The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis. J Neurosurg :1-9

Showing the most recent 10 out of 8799 publications